Affymetrix and IPSOGEN Collaborate to Develop and Market In-Vitro Diagnostic Cancer Tests
News Aug 29, 2007
Affymetrix Inc. and IPSOGEN has announced that they have signed a Powered by Affymetrix™ (PbA) agreement. With this agreement, IPSOGEN gains non-exclusive access to Affymetrix microarray technology to develop and market in-vitro diagnostic (IVD) tests, initially for breast cancer, on a worldwide basis.
The PbA agreement enables IPSOGEN to incorporate Affymetrix arrays into its diagnostic products. The resulting microarray-based tests will enable clinicians to provide more efficient and complete methods to diagnose, classify and manage patients suffering from cancer.
"This agreement with Affymetrix, the world leader in microarray-based technology, provides IPSOGEN with the most advanced platform meeting the highest industry standards to support our new generation of IVD-profiling diagnostic products," said Vincent Fert, president and CEO of IPSOGEN.
"IPSOGEN's strong expertise in delivering high medical value IVD products in the field of blood cancers will be leveraged together with our new PbA capabilities to expedite the launch of a range of innovative and unique IVD tests for guiding breast cancer therapies," said Fert.
"The microarray-based tools and applications in the Powered by Affymetrix™ program continue to accelerate the discovery and development of oncology diagnostics products," said Noel Doheny, senior vice president, Molecular Diagnostics at Affymetrix. "This is the era of personalized medicine and we are pleased that another innovator in the molecular diagnostic field like IPSOGEN has adopted our proven technology platform."
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE
New Technique Eases Production, Customization of Soft RoboticsNews
By helping rubber and plastic stick together under pressure, University of Nebraska-Lincoln chemists have simplified the production of small fluid-carrying channels that can drive movement in soft robotics and enable chemical analyses on microscopic scales.READ MORE
New Preservation Method Maintains Viable CTCs for up to 72 HoursNews
A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells.READ MORE